Panagora Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Panagora Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-51,929	Closed	-$1.29M	–	1577
2022 Q2	$1.29M	Buy	51,929 +23,495	+83%	+$518K	0.01%	783
2022 Q1	$713K	Buy	28,434 +6,098	+27%	+$171K	﹤0.01%	1085
2021 Q4	$813K	Buy	22,336 +4,256	+24%	+$149K	﹤0.01%	1016
2021 Q3	$309K	Hold	18,080	–	–	﹤0.01%	1505
2021 Q2	$242K	Sell	18,080 -4,383	-20%	-$108K	﹤0.01%	1609
2021 Q1	$1.15M	Sell	22,463 -2,879	-11%	-$173K	0.01%	959
2020 Q4	$1.57M	Sell	25,342 -26	-0.1%	-$1.49K	0.01%	791
2020 Q3	$1.39M	Sell	25,368 -72,999	-74%	-$3.93M	0.01%	783
2020 Q2	$5.66M	Buy	98,367 +14,169	+17%	+$771K	0.04%	367
2020 Q1	$3.38M	Sell	84,198 -327,411	-80%	-$13.9M	0.02%	451
2019 Q4	$16.3M	Buy	411,609 +19,958	+5%	+$350K	0.07%	261
2019 Q3	$2.65M	Sell	391,651 -13,992	-3%	-$105K	0.01%	652
2019 Q2	$3.77M	Buy	405,643 +96,786	+31%	+$1.12M	0.02%	583
2019 Q1	$4.29M	Sell	308,857 -15,366	-5%	-$176K	0.02%	558
2018 Q4	$3.54M	Buy	324,223 +109	+0%	+$1.15K	0.02%	573
2018 Q3	$4.1M	Sell	324,114 -3,752	-1%	-$45.2K	0.02%	582
2018 Q2	$4.32M	Sell	327,866 -42,093	-11%	-$503K	0.02%	584
2018 Q1	$5.03M	Buy	369,959 +87,321	+31%	+$901K	0.02%	532
2017 Q4	$1.68M	Buy	282,638 +16,120	+6%	+$111K	0.01%	947
2017 Q3	$1.98M	Buy	266,518 +61,610	+30%	+$512K	0.01%	865
2017 Q2	$1.92M	Buy	204,908 +51,100	+33%	+$375K	0.01%	875
2017 Q1	$1.12M	Buy	153,808 +106,554	+225%	+$767K	﹤0.01%	1093
2016 Q4	$350K	Buy	+47,254	New	+$340K	﹤0.01%	1569
2015 Q3	–	Sell	-4,067	Closed	-$33K	–	2464
2015 Q2	$33K	Buy	+4,067	New	+$32.3K	﹤0.01%	2226

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Panagora Asset Management's CCXI Position: Q3 2022 in Review

Panagora Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 51,929 shares — an estimated $1.29M sold.

Panagora Asset Management first reported a position in CCXI in Q2 2015 and held it in 24 quarters. The position peaked at $16.3M in Q4 2019. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Panagora Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Panagora Asset Management sold 51,929 ChemoCentryx, Inc. shares in Q3 2022, an estimated $1.29M.
Panagora Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2015 and held it in 24 quarters.
Panagora Asset Management's ChemoCentryx, Inc. position peaked at $16.3M in Q4 2019.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.